317 related articles for article (PubMed ID: 29282351)
1. Marked 18-Fuorine-Fluorodeoxyglucose (FDG) Avidity of an Intrapulmonary Typical Carcinoid Tumor Manifesting as a Bronchocele in an Asymptomatic Middle-Aged Woman.
Saadé-Yordán C; McBurney-Henriquez E; González-Santoni R; Gurrea-Rosas C; Montalvo-Fitzpatrick J; Maldonado-Vargas JA
Am J Case Rep; 2017 Dec; 18():1390-1395. PubMed ID: 29282351
[TBL] [Abstract][Full Text] [Related]
2. The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules.
Daniels CE; Lowe VJ; Aubry MC; Allen MS; Jett JR
Chest; 2007 Jan; 131(1):255-60. PubMed ID: 17218584
[TBL] [Abstract][Full Text] [Related]
3. Growth of a solitary pulmonary nodule after 6years diagnosed as oncocytic carcinoid tumour with a high 18-fluorodeoxyglucose (18F-FDG) uptake in positron emission tomography-computed tomography (PET-CT).
Turan O; Ozdogan O; Gurel D; Onen A; Kargi A; Sevinc C
Clin Respir J; 2013 Jan; 7(1):e1-5. PubMed ID: 22129499
[TBL] [Abstract][Full Text] [Related]
4. Integrated FDG-PET/CT imaging is useful in the approach to carcinoid tumors of the lung.
Stefani A; Franceschetto A; Nesci J; Aramini B; Proli C; Kaleci S; Casolo A; Massi L; Casali C; Morandi U
J Cardiothorac Surg; 2013 Dec; 8():223. PubMed ID: 24305515
[TBL] [Abstract][Full Text] [Related]
5. [Pulmonary carcinoid tumors].
Prosch H
Radiologe; 2017 May; 57(5):397-406. PubMed ID: 28405692
[TBL] [Abstract][Full Text] [Related]
6. Multimodality imaging features in a case of bronchial carcinoid including FDG PET.
Shin V; Bhargava P; Brown J; Ames ED; Kang P
Med Sci Monit; 2007 Jan; 13(1):CS4-8. PubMed ID: 17179913
[TBL] [Abstract][Full Text] [Related]
7. Use of integrated FDG PET/CT imaging in pulmonary carcinoid tumours.
Krüger S; Buck AK; Blumstein NM; Pauls S; Schelzig H; Kropf C; Schumann C; Mottaghy FM; Hombach V; Reske SN
J Intern Med; 2006 Dec; 260(6):545-50. PubMed ID: 17116005
[TBL] [Abstract][Full Text] [Related]
8. FDG-PET imaging in patients with pulmonary carcinoid tumor.
Moore W; Freiberg E; Bishawi M; Halbreiner MS; Matthews R; Baram D; Bilfinger TV
Clin Nucl Med; 2013 Jul; 38(7):501-5. PubMed ID: 23486331
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of primary pulmonary carcinoid tumors using FDG PET.
Erasmus JJ; McAdams HP; Patz EF; Coleman RE; Ahuja V; Goodman PC
AJR Am J Roentgenol; 1998 May; 170(5):1369-73. PubMed ID: 9574618
[TBL] [Abstract][Full Text] [Related]
10. Atypical diagnosis for typical lung carcinoid.
Piro R; Tonelli R; Taddei S; Marchioni A; Musci G; Clini E; Facciolongo N
BMC Pulm Med; 2019 Sep; 19(1):168. PubMed ID: 31477066
[TBL] [Abstract][Full Text] [Related]
11. 18F-FDG PET/CT Diagnosis of Bronchopulmonary Carcinoids Versus Pulmonary Hamartomas.
Uhlén N; Grundberg O; Jacobsson H; Sundin A; Dobra K; Sánchez-Crespo A; Axelsson R; Kölbeck KG
Clin Nucl Med; 2016 Apr; 41(4):263-7. PubMed ID: 26828139
[TBL] [Abstract][Full Text] [Related]
12. Fluorodeoxyglucose positron emission tomography in pulmonary carcinoid tumors.
Gasparri R; Rezende GC; Fazio N; Maisonneuve P; Brambilla D; Travaini LL; Paganelli G; Petrella F; Galetta D; Spaggiari L
Q J Nucl Med Mol Imaging; 2015 Dec; 59(4):446-54. PubMed ID: 26416036
[TBL] [Abstract][Full Text] [Related]
13. Are the 18F-FDG positron emission tomography/computed tomography findings in bronchopulmonary carcinoid tumors different than expected?
Alpay L; Lacin T; Kanbur S; Kiral H; Ersoz E; Bayram S; Dogruyol T; Baysungur V; Yalcinkaya I
Hell J Nucl Med; 2013; 16(3):213-7. PubMed ID: 24251310
[TBL] [Abstract][Full Text] [Related]
14. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules.
Bryant AS; Cerfolio RJ
Ann Thorac Surg; 2006 Sep; 82(3):1016-20. PubMed ID: 16928527
[TBL] [Abstract][Full Text] [Related]
15. CT features of peripheral pulmonary carcinoid tumors.
Meisinger QC; Klein JS; Butnor KJ; Gentchos G; Leavitt BJ
AJR Am J Roentgenol; 2011 Nov; 197(5):1073-80. PubMed ID: 22021498
[TBL] [Abstract][Full Text] [Related]
16. Role of 68Ga-DOTATOC PET/CT in initial evaluation of patients with suspected bronchopulmonary carcinoid.
Venkitaraman B; Karunanithi S; Kumar A; Khilnani GC; Kumar R
Eur J Nucl Med Mol Imaging; 2014 May; 41(5):856-64. PubMed ID: 24435773
[TBL] [Abstract][Full Text] [Related]
17. Oncocytic carcinoid tumor of the lung with intense F-18 fluorodeoxyglucose (FDG) uptake in positron emission tomography-computed tomography (PET/CT).
Tanabe Y; Sugawara Y; Nishimura R; Hosokawa K; Kajihara M; Shimizu T; Takahashi T; Sakai S; Sawada S; Yamashita M; Ohtani H
Ann Nucl Med; 2013 Oct; 27(8):781-5. PubMed ID: 23757317
[TBL] [Abstract][Full Text] [Related]
18. Typical and atypical bronchopulmonary carcinoid tumors on FDG PET/CT imaging.
Wartski M; Alberini JL; Leroy-Ladurie F; De Montpreville V; Nguyen C; Corone C; Dartevelle P; Pecking AP
Clin Nucl Med; 2004 Nov; 29(11):752-3. PubMed ID: 15483502
[No Abstract] [Full Text] [Related]
19. The utility of 18F-FDG and 68Ga-DOTA-Peptide PET/CT in the evaluation of primary pulmonary carcinoid: A systematic review and meta-analysis.
Jiang Y; Hou G; Cheng W
Medicine (Baltimore); 2019 Mar; 98(10):e14769. PubMed ID: 30855482
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic imaging of typical lung carcinoids: relationship between MDCT,
Danti G; Berti V; Abenavoli E; Briganti V; Linguanti F; Mungai F; Pradella S; Miele V
Radiol Med; 2020 Aug; 125(8):715-729. PubMed ID: 32189174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
